During the past decade, Presbyterian Cancer Center at Presbyterian Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 46 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Presbyterian Cancer Center at Presbyterian Hospital" #1 sponsor was "Children's Oncology Group" with 31 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "Radiation Therapy Oncology Group" with 12 trials sponsored and "NSABP Foundation Inc" with 12 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Presbyterian Cancer Center at Presbyterian Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Presbyterian Cancer Center at Presbyterian Hospital" are "Leukemia" (20 trials), "Breast Cancer" (12 trials), "Lung Cancer" (12 trials), "Lymphoma" (11 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "Presbyterian Cancer Center at Presbyterian Hospital" in a lesser frequency.

Most popular intervention types in "Presbyterian Cancer Center at Presbyterian Hospital" are "Drug" (85 trials), "Biological" (35 trials), "Radiation" (32 trials), "Procedure" (27 trials) and "Other" (24 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (18 trials), "radiation therapy" (18 trials), "etoposide" (16 trials), "vincristine sulfate" (15 trials) and "filgrastim" (14 trials). Other intervention names were less common.

The vast majority of trials in "Presbyterian Cancer Center at Presbyterian Hospital" are 93 trials for "All" genders, 13 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Presbyterian Cancer Center at Presbyterian Hospital". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 100 completed trials in Presbyterian Cancer Center at Presbyterian Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Presbyterian Cancer Center at Presbyterian Hospital, 5 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".